TransMedics Group, Inc. Gains 40.33%

Wed, May 04, 2022 at 05:30 PM
TransMedics Group, Inc. Gains 40.33%

TransMedics Group, Inc. (TMDX:NASDAQ) soared at $30.69, a gain of 40.3%. The stock appeared on our News Catalysts scanner on Tue, May 03, 2022 at 06:32 PM in the 'EARNINGS' category. From Wed, Apr 20, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About TransMedics Group, Inc. (TMDX:NASDAQ)

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the OCS to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.